Literature DB >> 20545392

Differential effect of codeine on thermal nociceptive sensitivity in sleepy versus nonsleepy healthy subjects.

Caren L Steinmiller1, Timothy A Roehrs, Erica Harris, Maren Hyde, Mark K Greenwald, Thomas Roth.   

Abstract

Basal sleepiness-alertness modulates drug effects. Sleepiness produced by sleep restriction leads to increased nociceptive sensitivity, suggesting opioid analgesia may also be modulated by sleepiness-alertness. This study compared thermal nociceptive sensitivity in sleepy versus nonsleepy participants after codeine or placebo. Twelve healthy normal adults, 18 to 35 years of age, had an 8-hr nocturnal polysomnogram (NPSG) followed by a Multiple Sleep Latency Test (MSLT; Carskadon and Dement, 1987). All had sleep efficiencies > 80% on their NPSG; 6 had average MSLT >or= 8 min (nonsleepy group) and 6 had latencies < 8 min (sleepy group). Participants were assessed following 8-hr time-in-bed with standard MSLT, and nociceptive assessments (using a radiant heat stimulation method) were conducted the following day with codeine 30 mg b.i.d. (0900 and 1300) or placebo b.i.d. Finger withdrawal latency (FWL) in seconds was measured to 5 different heat intensities randomly presented to the index finger pad of each hand. Mean +/- 1 SD MSLT values in the sleepy group were 4.72 +/- 1.83 min and 13.04 +/- 4.90 min in the nonsleepy group. As hypothesized, increased FWL (decreased nociception) was observed with lower heat intensities, codeine, and in the nonsleepy group. More important, there was a Group x Drug interaction with codeine increasing FWL in the nonsleepy, but not the sleepy, group. These data show the analgesic effects of codeine are diminished in sleepy versus nonsleepy individuals. They suggest clinical differences in response to analgesics are partly explained by basal state of sleepiness-alertness.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20545392     DOI: 10.1037/a0018899

Source DB:  PubMed          Journal:  Exp Clin Psychopharmacol        ISSN: 1064-1297            Impact factor:   3.157


  12 in total

1.  Weighing the balance: how analgesics used in chronic pain influence sleep?

Authors:  Miqdad H Bohra; Chhavi Kaushik; Daniel Temple; Sharon A Chung; Colin M Shapiro
Journal:  Br J Pain       Date:  2014-08

2.  Decreased alertness due to sleep loss increases pain sensitivity in mice.

Authors:  Chloe Alexandre; Alban Latremoliere; Ashley Ferreira; Giulia Miracca; Mihoko Yamamoto; Thomas E Scammell; Clifford J Woolf
Journal:  Nat Med       Date:  2017-05-08       Impact factor: 53.440

3.  Self-reported sleep duration associated with distraction analgesia, hyperemia, and secondary hyperalgesia in the heat-capsaicin nociceptive model.

Authors:  Claudia M Campbell; Sara C Bounds; Mpepera B Simango; Kenneth R Witmer; James N Campbell; Robert R Edwards; Jennifer A Haythornthwaite; Michael T Smith
Journal:  Eur J Pain       Date:  2010-12-30       Impact factor: 3.931

4.  Sleep and pain in humans with fibromyalgia and comorbid insomnia: double-blind, crossover study of suvorexant 20 mg versus placebo.

Authors:  Timothy Roehrs; Dana Withrow; Gail Koshorek; Jelena Verkler; Luisa Bazan; Thomas Roth
Journal:  J Clin Sleep Med       Date:  2020-01-14       Impact factor: 4.062

5.  The Pronociceptive Effect of Paradoxical Sleep Deprivation in Rats: Evidence for a Role of Descending Pain Modulation Mechanisms.

Authors:  Dabna H Tomim; Felipe M Pontarolla; Jessica F Bertolini; Mauricio Arase; Glaucia Tobaldini; Marcelo M S Lima; Luana Fischer
Journal:  Mol Neurobiol       Date:  2015-02-24       Impact factor: 5.590

Review 6.  The association of sleep and pain: an update and a path forward.

Authors:  Patrick H Finan; Burel R Goodin; Michael T Smith
Journal:  J Pain       Date:  2013-12       Impact factor: 5.820

7.  Pain sensitivity and recovery from mild chronic sleep loss.

Authors:  Timothy A Roehrs; Erica Harris; Surilla Randall; Thomas Roth
Journal:  Sleep       Date:  2012-12-01       Impact factor: 5.849

8.  individual variation in sleep quality and duration is related to cerebral mu opioid receptor binding potential during tonic laboratory pain in healthy subjects.

Authors:  Claudia M Campbell; Sara C Bounds; Hiroto Kuwabara; Robert R Edwards; James N Campbell; Jennifer A Haythornthwaite; Michael T Smith
Journal:  Pain Med       Date:  2013-09-18       Impact factor: 3.750

Review 9.  Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendations.

Authors:  Robert R Edwards; Robert H Dworkin; Dennis C Turk; Martin S Angst; Raymond Dionne; Roy Freeman; Per Hansson; Simon Haroutounian; Lars Arendt-Nielsen; Nadine Attal; Ralf Baron; Joanna Brell; Shay Bujanover; Laurie B Burke; Daniel Carr; Amy S Chappell; Penney Cowan; Mila Etropolski; Roger B Fillingim; Jennifer S Gewandter; Nathaniel P Katz; Ernest A Kopecky; John D Markman; George Nomikos; Linda Porter; Bob A Rappaport; Andrew S C Rice; Joseph M Scavone; Joachim Scholz; Lee S Simon; Shannon M Smith; Jeffrey Tobias; Tina Tockarshewsky; Christine Veasley; Mark Versavel; Ajay D Wasan; Warren Wen; David Yarnitsky
Journal:  Pain       Date:  2016-09       Impact factor: 7.926

10.  Experimental pain and opioid analgesia in volunteers at high risk for obstructive sleep apnea.

Authors:  Anthony G Doufas; Lu Tian; Kevin A Padrez; Puntarica Suwanprathes; James A Cardell; Holden T Maecker; Periklis Panousis
Journal:  PLoS One       Date:  2013-01-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.